Efficacy of Cabergoline in Inhibiting Lactation and Alleviating Breast Symptoms

NCT07492160 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

348

Enrollment

OTHER

Sponsor class

Conditions

Pregnancy
Abortion

Interventions

DRUG: Cabergoline
DRUG: Placebo

Sponsor

Maimonides Medical Center